
Sign up to save your podcasts
Or


In this episode, Robert Hendershott and Yaron Brook discuss the progress of pharma-biotech and gene editing treatment in particular with reduction in tooth decay and the formidable costs of the FDA and overreach of government regulations.
Sign up for our newsletter at ingenuism.com.
By Robert Hendershott, Don Watkins, and Yaron BrookIn this episode, Robert Hendershott and Yaron Brook discuss the progress of pharma-biotech and gene editing treatment in particular with reduction in tooth decay and the formidable costs of the FDA and overreach of government regulations.
Sign up for our newsletter at ingenuism.com.